What\'s already known about this topic?
=======================================

Total-body naevus counts and dysplastic naevi are important risk factors for melanoma.Naevi with distinct dermoscopic patterns differ in size, anatomical and age distribution, and host pigmentation characteristics.

What does this study add?
=========================

We have identified associations between genetic variants and the number of naevi in early age.We have identified associations between host genetics and the dermoscopic pattern of naevi, supporting the hypothesis that naevi distinguished by their dermoscopic pattern represent distinct biological subsets.

Total-body naevus counts and dysplastic naevi are important risk factors for melanoma.[@b1] Understanding the pathways involved in naevogenesis is therefore relevant to public health efforts aimed at melanoma prevention. Cross-sectional[@b2] and longitudinal[@b3] studies have demonstrated that childhood and adolescence are critical periods for naevogenesis. Naevi are more common among those with fair skin, sun sensitivity[@b4],[@b5] and freckling, and their development is influenced by age, sex[@b4],[@b6] and sun exposure.[@b3],[@b7] Data from twin studies have suggested that naevi have a strong heritable component,[@b7]--[@b9] observations supported by subsequent candidate gene and genome-wide association studies. Gene variants implicated in naevus development thus far include those involved in pigmentation,[@b10],[@b11] cell-cycle regulation,[@b10] telomere function and senescence[@b12]--[@b14] and immune surveillance.[@b10],[@b15] Variants in DNA repair pathways, among others, were recently implicated in the development of dysplastic naevi.[@b16]

The understanding of naevus development in childhood has been advanced with the use of dermoscopy, which allows a more detailed morphological assessment of individual naevi and has led to a new classification proposal.[@b17] We have previously distinguished two subsets of naevi with distinct dermoscopic patterns (i.e. globular, reticular) that differ in size, anatomical and age distribution, and host pigmentation characteristics,[@b5] and that remain stable in pattern during preadolescence.[@b18] Furthermore, these dermoscopic patterns can be subtly recognized in normal-appearing skin,[@b19] suggesting an individual predisposition towards a given pattern. Based on our observations and those of others,[@b20]--[@b25] we hypothesize that the development of naevi is modulated by host genetic variants and that dermoscopically defined subsets of acquired naevi are biologically distinct.

This study aimed to evaluate potential associations between genetics and melanocytic naevus count and between genetics and dermoscopic naevus patterns in early life.

Materials and methods
=====================

Participants and data collection
--------------------------------

The study was approved by the Boston University and Harvard University institutional review boards. Student recruitment was conducted within the Framingham, Massachusetts, school system through the Study of Nevi in Children (SONIC) study. Details on the cohort and data collection procedures have been previously described.[@b4],[@b26] Briefly, children were enrolled in fifth grade (mean age 10·4 years) in 2004 and were prospectively followed up. At baseline, participants completed a questionnaire regarding sun exposure history, sun sensitivity and sun-related behaviour. In cases of missing student information on sun sensitivity, parent responses were used. A study nurse recorded phenotypic information on hair, eye and skin colour based on visual examination.

Naevus imaging
--------------

Digital overview images of the back were obtained for each participant using a Phase One P25 Camera Back, Hasselblad 503w Camera System, 1 kW Studio Flash System (Canfield Scientific, Inc., Fairfield, NJ, U.S.A.). Images were 5540 × 4080 pixels in size, allowing for close-up interrogation with minimal loss of image quality. Total back naevus counts were assessed from images by a study dermatologist. Each lesion was digitally tagged for reproducibility and quality assurance. In a random sample of 50 back images, interobserver concordance was high (ρ = 0·91).[@b4]

Dermoscopic patterns
--------------------

Detailed procedures have been reported by Scope *et al*.[@b5] Briefly, close-up clinical and dermoscopic images of up to four back naevi were obtained from each participant in the months of November and December, and included the largest naevus and randomly selected upper-back naevi, and a corresponding pair of lower-back naevi. Naevus size was assessed against standardized scales. Dermoscopic images were obtained using a Fuji S2 SLR digital camera (Fujifilm, Tokyo, Japan) and 60 mm Macro Nikkor lens (Nikon, Tokyo, Japan) with Epi-Lume™ attachment (Canfield Scientific, Inc.). Images were independently evaluated by two dermatologists for global dermoscopic patterns:[@b5],[@b27] (i) reticular -- diffuse or patchy network, without globules; (ii) globular -- globules present without network; (iii) homogeneous -- absence of network and globules; and (iv) complex -- both network and globules present. A dermoscopic pattern that could not be classified was denoted as 'other'. Disagreements between observers were resolved at a consensus session with an expert dermoscopist (A.A.M.).

Biospecimen collection
----------------------

Participants swirled 10 mL of water in their mouth for 40 s and the solution was collected in conical tubes. Samples were logged in student classrooms by a study coordinator, and sent to the University of New Mexico for DNA extraction with Qiagen DNA kits (Qiagen, Inc., Valencia, CA, U.S.A.) and Sanger sequencing of *MC1R*. DNA was shipped to the Molecular Epidemiology Laboratory at Memorial Sloan-Kettering for additional genotyping, as detailed below.

Genotyping
----------

*MC1R* was sequenced using a 1125-bp polymerase chain reaction-amplified fragment to cover the coding region. Information on primers and cycling parameters is detailed in [Data S1](#SD1){ref-type="supplementary-material"} (see Supporting Information). Excess nucleotides and primers were removed using shrimp alkaline phosphatase/exonuclease I using standard conditions. BigDye® terminator cycle sequencing followed under standard conditions using one of four primers to address the carboxy terminus, transmembrane and amino terminus regions ([Data S1](#SD1){ref-type="supplementary-material"}). Products were sequenced on an ABI Prism 3100 (Applied Biosystems, Foster City, CA, U.S.A.) and electropherograms were read by two independent reviewers using the Sequencher software v.4.05 (Gene Codes Corporation, Ann Arbor, MI, U.S.A.).

Additional genotyping included polymorphisms selected for their reported associations with naevi and melanoma risk, and their known or expected functional relevance based on laboratory data and *in silico* predictions.[@b28] We used the MassArray iPLEX chemistry and platform (Sequenom, San Diego, CA, U.S.A.). Genomic DNA (5--10 ng) was amplified using specific primers ([Table S1](#SD1){ref-type="supplementary-material"}; see Supporting Information), and the experimental procedures were similar to those previously described.[@b29] Cluster plots were evaluated with the TyperAnalyzer (MassARRAY v.4.0.20.65; Sequenom). Assays were considered optimal according to the degree of clustering and agreement within replicas. Selected single-nucleotide polymorphism (SNP) clusters and representative samples within the clusters were sequenced to confirm specificity. Rigorous quality-control procedures were implemented to avoid contamination. One sample failed across all assays and was removed from the study. Among the 96 SNPs tested in 361 specimens, 11 SNPs failed due to poor clustering and/or nonspecific extension. In total, 85 SNPs in genes associated with pigmentary, DNA repair, telomere/senescence and other pathways were successfully tested. The successful assays are described in [Table S2](#SD1){ref-type="supplementary-material"} (see Supporting Information) in relation to their associated known pathway, genomic context, chromosomal coordinate, alleles, minor allele frequency (MAF) and call rate.

Statistical analysis
--------------------

The primary outcome was the total number of naevi on each participant\'s back, transformed to the natural logarithm scale after adding a constant of 1 to account for those study subjects without any naevi, referred to as log naevus count. The log transformation is a variance-stabilizing transformation, which effectively compresses large values of the data while stretching smaller values, thus mitigating outlier issues for data points that may otherwise appear anomalous. The secondary outcome was dermoscopic pattern of naevi, a categorical variable taking four values: homogeneous, reticular, globular and complex patterns. Up to four naevi were evaluated for dermoscopic patterns in each study participant.

We used linear regression analysis to examine the association between SNPs and log naevus counts using a multivariable model, adjusted for race/ethnicity, sex and Sun Sensitivity Index ([Data S2](#SD1){ref-type="supplementary-material"}; see Supporting Information). For completeness, we also initially modelled each SNP individually, adjusted for the same factors. To address potential multiple comparison issues in the multivariate model, we used an empirical Bayes-type shrinkage analysis that shrinks the effects of seemingly null SNPs towards 0.[@b30] We also incorporated pathway information of the SNPs in this analysis, as detailed in [Table S2](#SD1){ref-type="supplementary-material"} (see Supporting Information), in two ways: firstly based on the *a priori* assumption that all SNPs within the same pathway conferred the same effect on the outcome, and next under the *a priori* assumption that each SNP conferred an effect that is inversely proportional to its MAF. SNPs having *P*-values \< 0·05 in the multivariate analyses were deemed significant. Interaction between the most significant SNP and sun exposure was examined using linear regression analysis by including product terms in the model. Additional methodological details can be found in [Data S2](#SD1){ref-type="supplementary-material"}.

We used polytomous regression to analyse dermoscopic patterns of naevi with homogeneous pattern as baseline, and by treating individuals as clusters. We excluded complex naevi from the analyses due to their limited sample size (*n* = 33). Due to the limited number of participants who were of ethnicity other than white non-Hispanic (40 Hispanic and 19 Asian, African American and Native American combined) ([Table S3](#SD1){ref-type="supplementary-material"}; see Supporting Information), we analysed the secondary outcomes using 76 SNPs in 735 naevi from 231 participants of non-Hispanic white ethnicity, after excluding SNPs having MAF \< 5%. We conducted a univariate analysis for each SNP without adjusting for any other variable. SNPs with *P* \< 0·10 in univariate analyses were prioritized for multivariate analysis. As some of these SNPs exhibited correlations, we fitted the final multivariate model using 12 SNPs. Due to the limited number of reticular naevi (*n* = 62) in our analyses, we used a bootstrap procedure with 200 bootstrap samples to estimate the standard errors of the odds ratios, and obtained the corresponding *P*-values.[@b31] We report SNPs having *P* \< 0·05 in multivariate analyses, and did not adjust the *P*-values for multiple comparisons due to the exploratory nature of our secondary analyses.

Results
=======

The demographic and phenotypic characteristics of the study participants are presented in Table [1](#tbl1){ref-type="table"}. There were 353 children (mean age 10·4 years, 136 female and 217 male) with available total back naevus counts and DNA for genetic analyses. Details on enrolment, participation and baseline findings are reported elsewhere.[@b4],[@b26] The participants were predominantly white non-Hispanic, had fair skin and a varying degree of sunburn propensity and tanning response. The average back naevus count was 9·2 (range 0--119). In total 853 naevi in 290 children were dermoscopically imaged, with the following distribution of dermoscopic patterns: 430 (50·4%) homogeneous, 298 (34·9%) globular, 92 (10·8%) reticular and 33 (3·9%) complex. The interrelationship between dermoscopic patterns, naevus size, anatomical location and phenotypic (pigmentary) characteristics were previously described for this cohort.[@b5]

###### 

Demographic and skin phenotypic characteristics of the 353 genotyped children

  Characteristic                                     Value[a](#tf1-1){ref-type="table-fn"}
  -------------------------------------------------- ---------------------------------------
  Age (years), mean ± SD                             10·4 ± 0·4
  Sex                                                
   Male                                              217 (61·5)
   Female                                            136 (38·5)
  Race/ethnicity                                     
   White                                             267 (75·6)
   Hispanic                                          56 (15·9)
   Asian                                             17 (4·8)
   African American                                  12 (3·4)
   Native American                                   1 (0·3)
  Skin colour                                        
   Very fair or fair                                 248 (70·3)
   Light olive                                       27 (7·6)
   Dark olive, brown, black                          78 (22·1)
  Hair colour                                        
   Blonde                                            22 (6·2)
   Blonde/light brown                                38 (10·8)
   Light brown                                       86 (24·4)
   Medium brown                                      101 (28·6)
   Red                                               12 (3·4)
   Dark brown                                        56 (15·9)
   Black                                             38 (10·8)
  Freckles                                           
   None                                              283 (80·2)
   Mild                                              55 (15·6)
   Moderate/severe                                   13 (3·7)
   Missing data                                      2 (0·6)
  Naevus count                                       
   Average ± SD                                      9·2 ± 11·2
   Median (IQR)                                      6 (9)
  Sunburn propensity                                 
   Yes                                               124 (35·1)
   No                                                229 (64·9)
  Tanning response                                   
   Yes, deep                                         103 (29·2)
   Yes, moderate                                     133 (37·7)
   Occasional, mild                                  60 (17·0)
   No, not able to tan                               19 (5·4)
   Unknown                                           25 (7·1)
   Missing data                                      13 (3·7)
  Sun exposure per day (summer prior to enrolment)   
   Low (\< 3 h)                                      107 (30·3)
   Medium (3--4 h)                                   139 (39·4)
   High (\> 4 h)                                     107 (30·3)
  Sun Sensitivity Index                              
   Range                                             0 (high) -- 3 (low)
   Mean ± SD                                         1·57 ± 0·77

IQR, interquartile range.

*n* (%) unless stated otherwise.

Sequencing of the *MC1R* gene identified a total of 30 variants in 272 (77·1%) children, including polymorphisms linked to red hair colour -- commonly termed 'R' (D84E, R142H, R151C, I155T, R160W and D294H)[@b32] in 44 children; other *MC1R* variants in 189 children; or both R and non-R variants (termed 'r') in 39 children. The characteristics of the *MC1R* variants found are displayed in [Table S4](#SD1){ref-type="supplementary-material"} (see Supporting Information).

The average call rate for 85 Sequenom-genotyped SNPs was 99·4% (range 95--100%), and the MAF ranged from 0·3% to 50%. For most of the candidate SNPs tested, the MAF in SONIC was similar to the MAF reported in dbSNP for white populations ([Table S2](#SD1){ref-type="supplementary-material"}; see Supporting Information). Five SNPs showed significant departure from the Hardy--Weinberg equilibrium (rs1129038, rs16891982, rs28777, rs12913832 and rs1426654; *P*-value \< 0·001). However, as we selected our candidate SNPs based on their known or anticipated association with naevogenesis or melanomagenesis, these SNPs were not categorically eliminated from the analyses based on departure from the Hardy--Weinberg equilibrium.

Association between polymorphisms and log naevus count
------------------------------------------------------

Results of the analysis of individual SNPs are shown in Table [2](#tbl2){ref-type="table"}. In multivariate analyses (Table [3](#tbl3){ref-type="table"}), the minor alleles of *IRF4* (rs12203592), *PARP1* (rs3219090), *CDK6* (rs2079147) and *PLA2G6* (rs738322) were significantly associated with either increased (rs12203592) or decreased (rs3219090, rs2079147, rs738322) naevus count in at least one of the multivariate methods considered, and two SNPs, in *PARP1* and in *APEX1*, displayed borderline significance.

###### 

Associations between individual genetic variants and log naevus count in the SONIC cohort

  SNP          MA   Gene               Pathway                            RR (95% CI)         *P*-value
  ------------ ---- ------------------ ---------------------------------- ------------------- -----------
  rs12203592   T    *IRF4*             Pigmentary traits; immune; other   1·67 (1·40--1·98)   \< 0·001
  rs2079147    G    *CDK6*             Cell cycle                         0·80 (0·66--0·96)   0·016
  rs1800407    A    *OCA2*             Pigmentation                       1·29 (1·03--1·62)   0·027
  rs872071     A    *IRF4*             Pigmentary traits; immune; other   0·81 (0·67--0·98)   0·028
  rs1129038    G    *HERC2*            Pigmentation                       1·23 (1·01--1·50)   0·041
  rs17132382   T    *POLN*             DNA repair                         0·82 (0·67--0·99)   0·046
  rs12913832   A    *HERC2*            Pigmentation                       1·22 (1·00--1·49)   0·047
  rs4150314    T    *ERCC5* (*XPG*)    DNA repair                         1·56 (0·99--2·42)   0·052
  rs28777      C    *SLC45A2*          Pigmentation                       0·81 (0·65--1·00)   0·054
  rs16891982   C    *SLC45A2*          Pigmentation                       0·82 (0·65--1·02)   0·075
  rs1760944    A    *APEX1* (*APE1*)   DNA repair                         0·86 (0·73--1·02)   0·082
  rs1042602    A    *TYR*              Pigmentation                       1·15 (0·98--1·36)   0·096
  rs2237570    T    *CDK6*             Cell cycle                         1·21 (0·97--1·51)   0·098

SNP, single-nucleotide polymorphism; MA, minor allele; RR, relative risk; CI, confidence interval. Analysis adjusted for sex, race/ethnicity and Sun Sensitivity Index (linear and quadratic). Analysis included all 353 children. *P* ≤ 0·05 is significant.

###### 

Associations between single-nucleotide polymorphism (SNPs) and log naevus count determined by standard and shrinkage-based multivariate regression in 353 children

  SNP          Gene       MA   MAF    Multivariate analysis[a](#tf3-1){ref-type="table-fn"}   Multivariate analysis[b](#tf3-2){ref-type="table-fn"}   Multivariate analysis[c](#tf3-3){ref-type="table-fn"}                                  
  ------------ ---------- ---- ------ ------------------------------------------------------- ------------------------------------------------------- ------------------------------------------------------- ---------- ------------------- ----------
  rs12203592   *IRF4*     T    0·18   1·56 (1·27--1·93)                                       \< 0·001                                                1·50 (1·24--1·80)                                       \< 0·001   1·49 (1·25--1·79)   \< 0·001
  rs3219090    *PARP1*    A    0·35   0·45 (0·23--0·87)                                       0·022                                                   0·77 (0·61--0·98)                                       0·033      0·77 (0·61--0·98)   0·037
  rs2079147    *CDK6*     G    0·48   0·81 (0·65--0·99)                                       0·049                                                   0·82 (0·68--0·97)                                       0·026      0·81 (0·68--0·96)   0·017
  rs738322     *PLA2G6*   A    0·50   0·55 (0·30--0·99)                                       0·049                                                   0·83 (0·66--1·05)                                       0·120      0·84 (0·70--1·05)   0·12
  rs2695238    *PARP1*    C    0·36   1·61 (0·88--2·94)                                       0·12                                                    1·24 (1·00--1·55)                                       0·054      1·23 (0·99--1·53)   0·059
  rs1760944    *APEX1*    A    0·40   0·84 (0·70--1·01)                                       0·072                                                   0·86 (0·73--1·01)                                       0·061      0·86 (0·74--1·01)   0·068
  rs1042602    *TYR*      A    0·32   1·20 (0·98--1·47)                                       0·080                                                   1·16 (0·98--1·36)                                       0·082      1·15 (0·98--1·35)   0·087
  rs1129038    *HERC2*    G    0·46   1·58 (0·30--8·25)                                       0·59                                                    1·12 (0·98--1·29)                                       0·093      1·12 (0·98--1·29)   0·097

MA, minor allele; MAF, overall MA frequency in SONIC/this study; RR, relative risk; CI, confidence interval.

Standard multivariate analysis;

Shrinkage estimation using pathway information;

Shrinkage estimation using pathway information considering MAF.

Adjusted for sex, race/ethnicity and Sun Sensitivity Index (linear and quadratic terms). *P* ≤ 0·05 is significant.

Interaction with sun exposure
-----------------------------

The top SNP from the analysis described above, *IRF4* rs12203592, was included in an analysis of interaction between genetics and sun exposure in relation to log naevus count at baseline. We found a borderline significant interaction ([anova]{.smallcaps} *P* = 0·057). As depicted in Figure[1](#fig01){ref-type="fig"}, among all 353 children (top left), those with the reference allele C presented average log naevus counts that increase in a dose--response manner as outdoor sun exposure (defined as the self-reported time spent outdoors in a typical day in the past summer) increases from low (\< 3 h) to medium (3--4 h) to high (\> 4 h). In the presence of one or two variant T alleles, the mean log back naevus count is higher even among those who reported low levels of sun exposure. The naevus count continues to rise as sun exposure increases from low to medium, but remains unchanged with higher levels of exposure. Similar patterns are observed among non-Hispanic white children (top right), regardless of sex (bottom panels).

![Average baseline log count of back naevi in relation to sun exposure among children according to *IRF4* rs12203592 genotypes.](bjd0172-1081-f1){#fig01}

Associations between polymorphisms and dermoscopic patterns
-----------------------------------------------------------

We identified five significant associations (*P* \< 0·05; Table [4](#tbl4){ref-type="table"}): SNPs in *IRF4* and *TERT* showed significant associations with globular patterns, while SNPs in *CDKN1B*, *MTAP* and *PARP1* showed significant associations with reticular-patterned naevi (compared with homogeneous-patterned naevi). An SNP in *CDK6* showed borderline significance with reticular-patterned naevi.

###### 

Associations between single-nucleotide polymorphism (SNPs) and reticular and globular dermoscopic patterns in relation to homogeneous patterns in 712 naevi from 231 non-Hispanic white children

  SNP          Gene        Pathway                            MA   MAF    RR -- globular vs. homogeneous pattern (95% CI)   *P*-value   RR -- reticular vs. homogeneous pattern (95% CI)   *P*-value
  ------------ ----------- ---------------------------------- ---- ------ ------------------------------------------------- ----------- -------------------------------------------------- -----------
  rs12203592   *IRF4*      Pigmentary traits; immune; other   T    0·18   0·59 (0·38--0·84)                                 0·014       0·91 (0·41--1·89)                                  0·82
  rs2853676    *TERT*      Telomere; senescence; repair       A    0·30   1·65 (1·09--2·65)                                 0·025       1·76 (0·88--4·90)                                  0·19
  rs7330       *CDKN1B*    Cell cycle                         C    0·50   0·71 (0·45--1·12)                                 0·15        0·42 (0·21--0·67)                                  0·011
  rs7023329    *MTAP*      Pigmentary traits                  A    0·49   0·75 (0·43--1·14)                                 0·26        0·39 (0·17--0·72)                                  0·017
  rs2695238    *PARP1*     DNA repair                         C    0·36   1·09 (0·77--1·62)                                 0·68        0·47 (0·20--0·94)                                  0·050
  rs2285332    *CDK6*      Cell cycle                         C    0·26   1·15 (0·75--1·91)                                 0·58        2·28 (1·09--5·66)                                  0·055
  rs12913832   *HERC2*     Pigmentation                       A    0·46   1·43 (0·98--2·16)                                 0·078       1·20 (0·53--2·50)                                  0·64
  Any r        *MC1R*      Pigmentation                       --   0·50   1·48 (0·86--2·68)                                 0·16        1·69 (0·78--4·04)                                  0·22
  rs26722      *SLC45A2*   Pigmentation                       T    0·07   1·53 (0·71--2·65)                                 0·16        2·26 (0·48--7·44)                                  0·23
  rs251796     *TERF2*     Telomere; senescence; repair       G    0·31   1·40 (0·88--2·11)                                 0·15        1·37 (0·65--3·02)                                  0·42
  rs4785763    *AFG3L1P*   Pigmentary traits                  A    0·29   1·22 (0·83--1·87)                                 0·32        0·73 (0·33--1·49)                                  0·47
  Any R        *MC1R*      Pigmentation                       --   0·10   1·16 (0·64--2·35)                                 0·64        0·79 (0·17--2·60)                                  0·74
  rs2736108    *TERT*      Telomere; senescence; repair       A    0·32   1·37 (0·92--2·07)                                 0·13        1·08 (0·49--2·50)                                  0·86

MA, minor allele; MAF, overall MA frequency in the full SONIC cohort/this study; RR, relative risk; CI, confidence interval. Analysis did not include adjustment for sex or Sun Sensitivity Index due to sparsity of data. *P* ≤ 0·05 is significant.

Discussion
==========

The Study of Naevi in Children (SONIC) is the first to document the clinical and dermoscopic evolution of individual naevi over time during adolescence. Here, we provide results to support the hypothesis that naevi distinguished by their dermoscopic pattern might represent distinct biological subsets. Additionally, we substantiate evidence that host genetic markers are associated with back naevus counts at age 10--11 years.

In this cohort, the *IRF4* rs12203952 polymorphism was very strongly associated with naevus count (Table [3](#tbl3){ref-type="table"}; *P* \< 0·001), in agreement with previous reports.[@b15],[@b33] Also, the rs12203952 T allele has been associated with increased counts of flat naevi and decreased counts of raised naevi;[@b15] this is also consistent with the inverse association between the rs12203952 T allele and globular naevi (Table [4](#tbl4){ref-type="table"}), which are mostly raised naevi. This SNP is known to disrupt a conserved melanocyte enhancer[@b34] within intron 4 of the interferon regulatory factor (IRF)4 gene (*IRF4*; previously reported as *MUM1*), a gene strongly expressed in melanoma and in junctional and compound naevi[@b35] that has potential antisurveillance or procarcinogenic activity.[@b36] We also demonstrate a modifying effect by sun exposure on back naevus count among those carrying rs12203952 T (Fig.[1](#fig01){ref-type="fig"}). Carriage of T alleles, compared with C, is linked to increased naevus count at any level of sun exposure; however, increased sun exposure from low-to-moderate levels contributes to additional naevi, suggesting that sun avoidance/protective measures may still have a valuable role in modulating melanoma risk in patients with T alleles. *In vitro* studies demonstrate a repressive effect of the allele C on the promoter activity; conversely, the T allele increases IRF4 expression when IRF4 is induced.[@b37] Praetorius *et al*., on the other hand, found lower IRF4 expression in foreskin melanocytes of subjects with the T allele compared with those with the C allele.[@b34] The rs12203952 T allele has a protective effect on melanoma in children and adolescents,[@b33] but the opposite effect has been reported for adults.[@b38],[@b39]

Poly (ADP-ribose) polymerase (PARP)1 is a key DNA repair enzyme involved in senescence,[@b40] cell death,[@b41] inflammation and immunity,[@b42],[@b43] and is strongly expressed in naevi.[@b44] *PARP1* rs3219090 is intronic, maps to a conserved region and is a likely candidate for a regulatory role. In our study, rs3219090 A is inversely associated with naevus count. This allele is also protective for melanoma.[@b45],[@b46] We observed that another SNP (*PARP1* rs2695238) was associated with naevus count with marginal significance (*P* \< 0·06) and displayed an inverse association (*P* = 0·05) with reticular-patterned naevi. This SNP has been linked to melanoma risk by others.[@b45]

The cell-cycle regulator *CDK6* was recently reported as the top gene associated with dysplastic naevi in melanoma-prone families.[@b16] In SONIC, the rs2079147 variant G is inversely associated with naevus count (*P* \< 0·05, Table [3](#tbl3){ref-type="table"}), and -- with a marginal significance -- with reticular-patterned naevi (*P* = 0·055). A number of SNPs were associated with dermoscopic pattern independent of naevus number (Table [4](#tbl4){ref-type="table"}). The *TERT* rs2853676 A allele was associated with globular-patterned naevi; it was reported by others as a melanoma susceptibility variant,[@b47] and might be associated with telomere length.[@b48] We also found negative associations between SNPs in *CDKN1B* and *MTAP* with reticular-patterned naevi. *CDKN1B* was recently linked to dysplastic naevi in melanoma families;[@b16] it encodes the cell-cycle regulator p27, and its function is progressively lost in the transition from benign naevi to primary and metastatic melanomas. *CDKN1B* rs7330 is a tag SNP with unknown function; however, its location in the 3′ untranslated region may implicate a regulatory function. Other studies on *MTAP* rs7023329 show a strong association between the variant and the number of naevi and large naevi. Although reports do not fully agree on the directionality of the effect,[@b49],[@b50] associations have been reported between this SNP and melanoma.[@b49],[@b51]--[@b53]

To our knowledge, this is the first population-based study on genetics in relation to naevus count and dermoscopic patterns in children. One recent study correlated genetics and dermoscopic features of melanocytic naevi in patients with multiple melanoma[@b54] and reported that among 62 naevi from 27 cases, vessels were more frequently observed among *CDKN2A* G101W mutation carriers, and atypia was more common among those carrying any *MC1R* variant. In our study in children we did not find significant associations between carriage of *MC1R* 'R+' or 'r+' variants and naevus counts. Another study evaluated phenotypic characteristics in 168 patients with melanoma and 126 unaffected individuals, and reported higher total naevus counts and a predominant reticular dermoscopic pattern among five of six individuals who were carriers of the rare MITF E318K germline mutation.[@b55]

In this study, we used a shrinkage estimation approach to shrink the effects of the seemingly null SNPs towards 0, as the proportion of null SNPs required to calculate the false discovery rate cannot be reliably estimated from our candidate SNP data. Previous work has established that the shrinkage estimation approach provides excellent false discovery control. We recognize that this study is limited by a modest number of study subjects and that naevus count and imaging were limited to the back. We focused on this anatomical site for logistical (examinations conducted in school during mandatory scoliosis checks) and epidemiological considerations (efficiency and imaging quality on flat skin surfaces).[@b4],[@b56] We were unable to adjust the analysis of SNPs and dermoscopic patterns for sex or sun sensitivity due to data sparseness. Similarly, the relatively small number of subjects limits the investigation of several SNPs in the nonwhite groups; therefore, we limited the investigation to white children. Our analyses will need to be reproduced with larger, independent cohorts. Finally, we recognize that in some instances the dermoscopic pattern might change during the development of naevi,[@b57] and this could potentially contribute to some statistical instability. However, most patterns remain stable during preadolescence.[@b18]

In conclusion, we show here that genetics are associated with both dermoscopic pattern and number of naevi in children of preadolescent age. Additional analyses in larger cohorts are warranted to confirm and extend our findings. Identification of potentially distinct biological melanocytic pathways will, in time, improve the current knowledge of naevogenesis and melanomagenesis. Recognition of distinct subsets of naevi might improve risk stratification with the potential to impact the biopsy threshold and surveillance frequency for high-risk phenotypes.

We thank Alan Geller (Harvard School of Public Health, Society, Human Development, and Health) for his continued collaboration on this project. We thank Marilyn Bishop, the teachers and staff in the Framingham School System, and the parents and students for participating in this study. We thank Youming Xu for his assistance with genetics data management and Joseph Kanik for assistance with graphics.

Supporting Information
======================

Additional Supporting Information may be found in the online version of this article at the publisher\'s website:

**Table S1.** Primer sequences and assay conditions for the testing of genetic variants in SONIC.

**Table S2.** Genomic position, genomic context, and minor allele frequencies of SNPs included in the study of host genetics in relation to nevus count and nevus patterns.

**Table S3.** Distribution of genotype frequencies according to dermoscopic patterns, race/ethnicity, and gender.

**Table S4.** Type and frequency of *MC1R* variants found in the SONIC cohort, overall and by race/ethnicity.

**Data S1.** Supplementary methods: MC1R sequencing.

**Data S2.** Supplementary methods: statistical analyses.

[^1]: **Funding sources** Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health NIH under award number AR049342, by the NIH award R01-CA137420, the Clinical and Translational Science Center of Weill Cornell Medical College award UL1TR000457, and the NCI CCSG award P30-CA008748.

[^2]: **Conflicts of interest** None declared.
